Sanofi Comprehensive Income Attributable To Noncontrolling Interests
Sanofi (SNY) reported Comprehensive Income Attributable To Noncontrolling Interests of -EUR 6.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests · last filed 2026-02-17
| Period end | Comprehensive Income Attributable To Noncontrolling Interests 6 month | Comprehensive Income Attributable To Noncontrolling Interests 12 month |
|---|---|---|
| 2025-12-31 | -6.00M EUR 20-F · filed 2026-02-17 | |
| 2025-06-30 | -13.00M EUR 6-K · filed 2025-10-27 | |
| 2024-12-31 | 80.00M EUR 20-F · filed 2026-02-17 | |
| 2024-06-30 | 25.00M EUR 6-K · filed 2025-10-27 | |
| 2023-12-31 | 23.00M EUR 20-F · filed 2026-02-17 | |
| 2023-06-30 | 18.00M EUR 6-K · filed 2024-07-25 | |
| 2022-12-31 | 118.00M EUR 20-F · filed 2025-02-13 | |
| 2022-06-30 | 72.00M EUR 6-K · filed 2023-07-28 | |
| 2021-12-31 | 67.00M EUR 20-F · filed 2024-02-23 | |
| 2021-06-30 | 22.00M EUR 6-K · filed 2022-07-28 | |
| 2020-12-31 | 16.00M EUR 20-F · filed 2023-02-24 | |
| 2020-06-30 | 12.00M EUR 6-K · filed 2021-07-29 | |
| 2019-12-31 | 30.00M EUR 20-F · filed 2022-02-23 | |
| 2019-06-30 | 16.00M EUR 6-K · filed 2020-07-29 | |
| 2018-12-31 | 100.00M EUR 20-F · filed 2021-03-04 | |
| 2017-12-31 | 106.00M EUR 20-F · filed 2020-03-05 | |
| 2016-12-31 | 94.00M EUR 20-F · filed 2019-03-08 | |
| 2015-12-31 | 107.00M EUR 20-F/A · filed 2018-03-16 |